Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Dose Comparison in Advanced GIST (EORTC 62005)
NCT00685828Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2001
- Primary completion
- Feb 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00685828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685828.